User profiles for Atin Jindal

Atin Jindal

Assistant Professor of Medicine, Clinician Educator, Alpert Medical School-Brown University
Verified email at lifespan.org
Cited by 37

Association of treatment with remdesivir and 30-day hospital readmissions in patients hospitalized with COVID-19

A Finn, A Jindal, SB Andrea, V Selvaraj… - The American journal of …, 2022 - Elsevier
Background Since the beginning of COVID-19 pandemic, there has been a widespread use
of remdesivir in adults and children. There is little known information about remdesivir's role …

[PDF][PDF] Presentations and outcomes of severe cardiac complications in COVID-19: Rhode Island experience

MD Arkadiy Finn, A Jindal… - Rhode Island Medical …, 2021 - researchgate.net
Forty-one (41) patients admitted to Rhode Island hospitals with COVID-19 from April to
November 2020 were identified to have severe cardiac complications. Clinical presentations of …

[HTML][HTML] Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease

…, A Lal, A Finn, JR Tanzer, M Baig, A Jindal… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Since the beginning of corona virus disease 2019 (COVID-19) pandemic,
there has been a widespread use of remdesivir in adults and children. There is little known …

[HTML][HTML] Incidence of neutropenic fever at a safety net hospital in cancer chemotherapy patients receiving prophylactic pegfilgrastim manual injection compared to the …

A Jindal, J Kover, V Raduka, TE O'Brien - Blood, 2018 - Elsevier
Introduction Febrile neutropenia (FN) is a potentially life-threatening complication of
chemotherapy, with increased incidence in pts receiving high risk chemotherapy regimens and/or …

[HTML][HTML] Misguided Artificial Intelligence: How Racial Bias is Built Into Clinical Models

A Jindal - Journal of Brown Hospital Medicine, 2022 - bhm.scholasticahq.com
Artificial Intelligence is being used today to solve a myriad of problems. While there is significant
promise that AI can help us address many healthcare issues, there is also concern that …

[HTML][HTML] Readmission Risk after COVID-19 Hospitalization: A Moderation Analysis by Vital Signs

A Finn, JR Tanzer, A Jindal, V Selvaraj… - Southern Medical …, 2022 - ncbi.nlm.nih.gov
Objective: Readmission to the hospital after hospitalization with coronavirus disease 2019 (COVID-19)
is associated with significant morbidity and mortality. Hospital clinicians may …

[HTML][HTML] Remdesivir in COVID-19 patients with end stage renal disease on hemodialysis

V Selvaraj, K Herman, A Finn, A Jindal… - Archives of …, 2021 - scientificarchives.com
To date, only glucocorticoids have been shown to reduce mortality in COVID-19. Use of
remdesivir was associated with reduced length of stay in hospitalized COVID-19 patients. A …

Disease Severity in Vaccinated Adults Hospitalized with Breakthrough COVID-19

A Finn, V Selvaraj, A Jindal, JR Tanzer, A Lal… - Hospital …, 2022 - Taylor & Francis
Background: Vaccination against SARS-CoV-2 is widely used and confers protection against
morbidity and mortality in COVID-19. Little is known about disease severity and outcomes …

Outcomes of COVID-19 among Patients with End Stage Renal Disease on Remdesivir

V Selvaraj, M Baig, K Dapaah-Afriyie, A Finn, A Jindal… - medRxiv, 2021 - medrxiv.org
BACKGROUND Since the beginning of the COVID-19 pandemic, there has been widespread
use of remdesivir in adults and children. There is little known information about its …

EFFICACY AND SAFETY OF VITAMIN K ANTAGONISTS VERSUS DIRECT ORAL ANTICOAGULANTS FOR ATRIAL FIBRILLATION AFTER TRANSCATHETER …

V Selvaraj, MS Khan, A Contos, A Jindal… - Journal of the American …, 2022 - jacc.org
Background: Patients undergoing transcatheter aortic valve replacement (TAVR) with
concomitant atrial fibrillation (AF) are at high risk for thromboembolic and bleeding events. The …